Athena Kerin, | |
5000 Avenue K, Brooklyn, NY 11234-2202 | |
(718) 250-8259 | |
Not Available |
Full Name | Athena Kerin |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 11 Years |
Location | 5000 Avenue K, Brooklyn, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396155883 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367H00000X | Anesthesiologist Assistant | 535903-1 (New York) | Secondary |
367500000X | Nurse Anesthetist, Certified Registered | 535903 (New York) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Optum Medical Care Pc | 9931013240 | 998 |
News Archive
A promising new drug therapy used to treat abnormal swelling in the eye - a condition called diabetic macular edema - proved less effective than traditional laser treatments in a study funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH).
Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.
In an analysis of studies that examined critically ill patients requiring an increase in blood fluid volume, intravenous use of the fluid hydroxyethyl starch was not associated with decreased mortality, according to an article appearing in the February 20 issue of JAMA.
"The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Development Programme (UNDP) today launched a new issue brief", titled "TRIPS transition period extensions for least-developed countries [LDCs]," a UNAIDS press release reports.
Austrian biomarker developer BIOCRATES Life Sciences AG announced today that it entered a co-marketing agreement with Canadian-based CHENOMX Inc. Both enterprises focus on a new and highly promising technology aimed at generating a metabolic profile of the human organism that can be used to monitor the effects of disease, nutrition, toxins, environment, or drugs on an organism.
› Verified 6 days ago
Entity Name | Optum Medical Care Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982643003 PECOS PAC ID: 9931013240 Enrollment ID: O20031119000321 |
News Archive
A promising new drug therapy used to treat abnormal swelling in the eye - a condition called diabetic macular edema - proved less effective than traditional laser treatments in a study funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH).
Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.
In an analysis of studies that examined critically ill patients requiring an increase in blood fluid volume, intravenous use of the fluid hydroxyethyl starch was not associated with decreased mortality, according to an article appearing in the February 20 issue of JAMA.
"The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Development Programme (UNDP) today launched a new issue brief", titled "TRIPS transition period extensions for least-developed countries [LDCs]," a UNAIDS press release reports.
Austrian biomarker developer BIOCRATES Life Sciences AG announced today that it entered a co-marketing agreement with Canadian-based CHENOMX Inc. Both enterprises focus on a new and highly promising technology aimed at generating a metabolic profile of the human organism that can be used to monitor the effects of disease, nutrition, toxins, environment, or drugs on an organism.
› Verified 6 days ago
Entity Name | North American Partners In Anesthesia Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649264706 PECOS PAC ID: 7719885771 Enrollment ID: O20040108000176 |
News Archive
A promising new drug therapy used to treat abnormal swelling in the eye - a condition called diabetic macular edema - proved less effective than traditional laser treatments in a study funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH).
Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.
In an analysis of studies that examined critically ill patients requiring an increase in blood fluid volume, intravenous use of the fluid hydroxyethyl starch was not associated with decreased mortality, according to an article appearing in the February 20 issue of JAMA.
"The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Development Programme (UNDP) today launched a new issue brief", titled "TRIPS transition period extensions for least-developed countries [LDCs]," a UNAIDS press release reports.
Austrian biomarker developer BIOCRATES Life Sciences AG announced today that it entered a co-marketing agreement with Canadian-based CHENOMX Inc. Both enterprises focus on a new and highly promising technology aimed at generating a metabolic profile of the human organism that can be used to monitor the effects of disease, nutrition, toxins, environment, or drugs on an organism.
› Verified 6 days ago
Entity Name | East Manhattan Anesthesia Partners, Llc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740436773 PECOS PAC ID: 9335207059 Enrollment ID: O20081024000449 |
News Archive
A promising new drug therapy used to treat abnormal swelling in the eye - a condition called diabetic macular edema - proved less effective than traditional laser treatments in a study funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH).
Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.
In an analysis of studies that examined critically ill patients requiring an increase in blood fluid volume, intravenous use of the fluid hydroxyethyl starch was not associated with decreased mortality, according to an article appearing in the February 20 issue of JAMA.
"The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Development Programme (UNDP) today launched a new issue brief", titled "TRIPS transition period extensions for least-developed countries [LDCs]," a UNAIDS press release reports.
Austrian biomarker developer BIOCRATES Life Sciences AG announced today that it entered a co-marketing agreement with Canadian-based CHENOMX Inc. Both enterprises focus on a new and highly promising technology aimed at generating a metabolic profile of the human organism that can be used to monitor the effects of disease, nutrition, toxins, environment, or drugs on an organism.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Athena Kerin, 2 Catharine St, P O Box 550, Poughkeepsie, NY 12601-3100 Ph: (845) 790-2661 | Athena Kerin, 5000 Avenue K, Brooklyn, NY 11234-2202 Ph: (718) 250-8259 |
News Archive
A promising new drug therapy used to treat abnormal swelling in the eye - a condition called diabetic macular edema - proved less effective than traditional laser treatments in a study funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH).
Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.
In an analysis of studies that examined critically ill patients requiring an increase in blood fluid volume, intravenous use of the fluid hydroxyethyl starch was not associated with decreased mortality, according to an article appearing in the February 20 issue of JAMA.
"The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Development Programme (UNDP) today launched a new issue brief", titled "TRIPS transition period extensions for least-developed countries [LDCs]," a UNAIDS press release reports.
Austrian biomarker developer BIOCRATES Life Sciences AG announced today that it entered a co-marketing agreement with Canadian-based CHENOMX Inc. Both enterprises focus on a new and highly promising technology aimed at generating a metabolic profile of the human organism that can be used to monitor the effects of disease, nutrition, toxins, environment, or drugs on an organism.
› Verified 6 days ago
Stephanie Joseph, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 506 6th St, Ny Methodist Hospital, Brooklyn, NY 11215 Phone: 718-780-3000 | |
Nikia S Nelson, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 506 6th Street, Ny Methodist Hospital, Brooklyn, NY 11215 Phone: 718-780-3279 Fax: 718-780-3281 | |
Mark Lieberman, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4802 10th Ave, Brooklyn, NY 11219 Phone: 718-283-8816 | |
Marina Hanukoff, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 506 6th Street, Ny Methodist Hospital, Brooklyn, NY 11215 Phone: 718-780-3279 | |
Ms. Margaret Mary Gill, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Poly Pl, Brooklyn, NY 11209 Phone: 718-439-4163 | |
Ms. Rita M Riley, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 150 55th Street, Brooklyn, NY 11220 Phone: 718-630-7452 Fax: 718-630-6322 | |
Ronell S Kirkley, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-3279 |